Beyond CTS5 score: A novel nomogram predicting long-term prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer
We confirmed the prognostic value of CTS5 in HR+/HER2+ breast cancer and developed a new nomogram with superior predictive performance for long-term prognosis compared to CTS5.
Authors
- Liang Qin (ORCID: https://orcid.org/0000-0003-1471-3872)
- Jiayi Wu (ORCID: https://orcid.org/0000-0001-5371-8989)
- Mingqi Zhang (ORCID: https://orcid.org/0000-0003-4888-2877)
- Jing Yu (ORCID: https://orcid.org/0009-0003-2656-9625)
Institutions
- Changzhi University (CN)
- Changzhi Medical College (CN)
- Ruijin Hospital (CN)
- Fourth People's Hospital of Taiyuan (CN)
Publication Details
- Journal
- Current Problems in Cancer
- Published
- 2025-04-05
- DOI
- https://doi.org/10.1016/j.currproblcancer.2025.101201
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00